miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs-Reference-Cited by-同舟云学术

miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs

Published:2013-04 Issue:2 Volume:15 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Riaz Muhammad,van Jaarsveld Marijn TM,Hollestelle Antoinette,Prager-van der Smissen Wendy JC,Heine Anouk AJ,Boersma Antonius WM,Liu Jingjing,Helmijr Jean,Ozturk Bahar,Smid Marcel,Wiemer Erik A,Foekens John A,Martens John WM

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr3415.pdf

Reference66 articles.

1. Pasquinelli AE: MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet. 2012, 13: 271-282.

2. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004, 116: 281-297. 10.1016/S0092-8674(04)00045-5.

3. Alvarez-Garcia I, Miska EA: MicroRNA functions in animal development and human disease. Development. 2005, 132: 4653-4662. 10.1242/dev.02073.

4. Zhao Y, Srivastava D: A developmental view of microRNA function. Trends Biochem Sci. 2007, 32: 189-197. 10.1016/j.tibs.2007.02.006.

5. Enerly E, Steinfeld I, Kleivi K, Leivonen SK, Aure MR, Russnes HG, Rønneberg JA, Johnsen H, Navon R, Rødland E, Mäkelä R, Naume B, Perälä M, Kallioniemi O, Kristensen VN, Yakhini Z, Børresen-Dale AL: miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLoS One. 2011, 6: e16915-10.1371/journal.pone.0016915.

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SLC7A11 protects luminal A breast cancer cells against ferroptosis induced by CDK4/6 inhibitors;Redox Biology;2024-10

2. Glucocorticoid receptor-mediated oncogenic activity is dependent on breast cancer subtype;The Journal of Steroid Biochemistry and Molecular Biology;2024-10

3. 2-methoxyestradiol inhibits the malignant behavior of triple negative breast cancer cells by altering their miRNome;Frontiers in Oncology;2024-09-12

4. KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges;Molecular Cancer;2024-05-20

5. Molecular interactions between metformin and D-limonene inhibit proliferation and promote apoptosis in breast and liver cancer cells;BMC Complementary Medicine and Therapies;2024-05-06